Our results strongly suggested that MRGBP promote PDAC progression, which is similar to the previous studies in other types of cancer, such as prostate cancer, colorectal cancer, cervical cancer and squamous cell carcinoma [9–12]. This evidence concerns the gene MRGBP and prostate carcinoma.